Meyka Pro is live. Get 50% off your first 3 months.Get Started →
Meyka Pro banner
Starling Oncology Inc. Wt

Starling Oncology Inc. Wt (STLNW) Stock Overview

Explore Starling Oncology Inc. Wt’s financial performance, market position, analyst ratings, and future outlook.

STLNW●NASDAQ
HealthcareMedical - Care Facilities
$0.06
$0.003(4.83%)
U.S. Market opens in 54h 53m

Starling Oncology Inc. Wt (STLNW)

Meyka AI Score

Z

Key Financials

Market Cap5.5M
P/E RatioN/A
EPS (TTM)N/A
ROEN/A
Fundamental Analysis

AI Price Forecasts

1 Month$0.01
3 Months$0.00
1 Year TargetN/A

STLNW Stock Analysis & Investment Overview (NASDAQ)

Our AI-powered analysis of Starling Oncology Inc. Wt (NASDAQ: STLNW) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of C+, Starling Oncology Inc. Wt's NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of STLNW on the NASDAQ shows an RSI of 43.82, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $N/A for the NASDAQ listing.

Key metrics behind Starling Oncology Inc. Wt's NASDAQ-traded stock include a P/E ratio of N/A and a market capitalization of 5.5M. Combined with our AI analysis, these give both institutional and retail investors a clear view of STLNW on the NASDAQ.

Price Performance (NASDAQ: STLNW)

1-Day Change
-4.83%
5-Day Change
9.96%
1-Month Change
12.88%
3-Month Change
12.88%
6-Month Change
12.88%
Year-to-Date (YTD) Change
12.88%
1-Year Change
12.88%
3-Year Change
12.88%
5-Year Change
12.88%
All-Time (Max) Change
12.88%

Contact Information

https://www.starlingoncology.com
NaN
18000 Studebaker Road, Cerritos, CA, 90703

Company Facts

6,410 Employees
IPO DateAug 4, 2026
CountryUS
Actively Trading

Frequently Asked Questions